Interstitial lung change in pre-radiation therapy computed tomography is a risk factor for severe radiation pneumonitis

Cancer Research and Treatment

Volumn 47, Issue 4, 2015, Pages 676-686

  Lee, Yun Hee ^a   Kim, Yeon Sil ^a   Lee, Sang Nam ^a   Lee, Hyo Chun ^a   Oh, Se Jin ^a   Kim, Seoung Joon ^a   Kim, Young Kyoon ^a   Han, Dae Hee ^a   Yoo, Ie Ryung ^a   Kang, Jin Hyung ^a   Hong, Suk Hee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Interstitial lung diseases; Lung neoplasms; Radiation pneumonitis; Radiotherapy

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RADIATION PNEUMONIA; COMPLICATION; DIAGNOSTIC IMAGING; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; RADIATION RESPONSE; RADIOMETRY; RISK FACTOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOMETRY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84946734769     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2014.180     Document Type: Article

References (22)

1. Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol. 1998;16:3316-22.
2. Toschi L, Cappuzzo F, Janne PA. Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer. Ann Oncol. 2007;18 Suppl 9:ix150-5.
3. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618-24.
4. De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol. 2006;17:543-52.
5. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys. 1995;31:361-9.
6. McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys. 1995;31:1187-203.
7. Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012;51:975-83.
8. Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;85:444-50.
9. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, et al. Dosevolume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol. 2009;91:427-32.
10. Baker R, Han G, Sarangkasiri S, DeMarco M, Turke C, Stevens CW, et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2013;85:190-5.
11. Dang J, Li G, Ma L, Diao R, Zang S, Han C, et al. Predictors of grade " 2 and grade " 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with threedimensional conformal radiotherapy. Acta Oncol. 2013;52: 1175-80.
12. Park YH, Kim JS. Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer. Radiat Oncol J. 2013;31: 34-40.
13. Togashi Y, Masago K, Handa T, Tanizawa K, Okuda C, Sakamori Y, et al. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer. Clin Lung Cancer. 2012;13:304-11.
14. Yamaguchi S, Ohguri T, Ide S, Aoki T, Imada H, Yahara K, et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer. 2013;82:260-5.
15. Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys. 2009;75:343-7.
16. Yamaguchi S, Ohguri T, Matsuki Y, Yahara K, Oki H, Imada H, et al. Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis. Int J Clin Oncol. 2015;20:45-52.
17. Sanuki N, Ono A, Komatsu E, Kamei N, Akamine S, Yamazaki T, et al. Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy. J Radiat Res. 2012;53:110-6.
18. Mueller-Mang C, Grosse C, Schmid K, Stiebellehner L, Bankier AA. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27:595-615.
19. Das SK, Zhou S, Zhang J, Yin FF, Dewhirst MW, Marks LB. Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees. Int J Radiat Oncol Biol Phys. 2007;68:1212-21.
20. Makimoto T, Tsuchiya S, Hayakawa K, Saitoh R, Mori M. Risk factors for severe radiation pneumonitis in lung cancer. Jpn J Clin Oncol. 1999;29:192-7.
21. Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol. 2010;20:201-7.
22. Yamashita H, Kobayashi-Shibata S, Terahara A, Okuma K, Haga A, Wakui R, et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol. 2010;5:32.